We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$8.1B
AUM Growth
+$4.9B
Cap. Flow
+$4.22B
Cap. Flow %
52.11%
Top 10 Hldgs %
26.76%
Holding
6,444
New
505
Increased
3,426
Reduced
1,637
Closed
524

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$314M
2
AAPL icon
Apple
AAPL
+$247M
3
MSFT icon
Microsoft
MSFT
+$235M
4
AMZN icon
Amazon
AMZN
+$110M
5
NVDA icon
NVIDIA
NVDA
+$99M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$21.7M
2
VNQ icon
Vanguard Real Estate ETF
VNQ
+$13.8M
3
SPLV icon
Invesco S&P 500 Low Volatility ETF
SPLV
+$12.8M
4
USO icon
United States Oil Fund
USO
+$12.5M
5
IBB icon
iShares Biotechnology ETF
IBB
+$12M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Financials 11.29%
3 Healthcare 10.69%
4 Consumer Discretionary 10.28%
5 Industrials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ODD icon
3726
ODDITY Tech
ODD
$615M
$17.9K ﹤0.01%
385
-775
-67% -$26.2K
NPK icon
3727
National Presto Industries
NPK
$998M
$17.9K ﹤0.01%
223
-303
-58% -$23.3K
FNWD icon
3728
Finward Bancorp
FNWD
$195M
$17.9K ﹤0.01%
708
+172
+32% +$3.67K
PCY icon
3729
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.4B
$17.8K ﹤0.01%
863
-357
-29% -$6.75K
ETON icon
3730
Eton Pharmaceutcials
ETON
$1.12B
$17.8K ﹤0.01%
4,062
+2,890
+247% +$11.6K
SLQT icon
3731
SelectQuote
SLQT
$126M
$17.7K ﹤0.01%
12,947
+8,066
+165% +$10.5K
CBNK icon
3732
Capital Bancorp
CBNK
$617M
$17.7K ﹤0.01%
731
-499
-41% -$10.5K
QUAL icon
3733
iShares MSCI USA Quality Factor ETF
QUAL
$48.4B
$17.7K ﹤0.01%
120
-707
-85% -$97.9K
OTEX icon
3734
Open Text
OTEX
$6.02B
$17.6K ﹤0.01%
419
-2,376
-85% -$89.2K
NWFL icon
3735
Norwood Financial Corp
NWFL
$376M
$17.5K ﹤0.01%
531
-122
-19% -$3.43K
PWOD
3736
DELISTED
Penns Woods Bancorp
PWOD
$17.4K ﹤0.01%
775
+169
+28% +$3.58K
OPFI icon
3737
OppFi
OPFI
$608M
$17.4K ﹤0.01%
3,404
-708
-17% -$2.25K
KORE
3738
DELISTED
KORE Group Holdings
KORE
$17.4K ﹤0.01%
3,552
+1,509
+74% +$4.34K
KNOP icon
3739
KNOT Offshore Partners
KNOP
$362M
$17.4K ﹤0.01%
3,021
+2,668
+756% +$15.6K
WEYS icon
3740
Weyco Group
WEYS
$446M
$17.4K ﹤0.01%
554
-239
-30% -$6.78K
SACH
3741
Sachem Capital Corp
SACH
$37.6M
$17.4K ﹤0.01%
4,640
+1,820
+65% +$6.5K
HEFA icon
3742
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.81B
$17.3K ﹤0.01%
549
-43
-7% -$1.31K
DGICA icon
3743
Donegal Group Class A
DGICA
$692M
$17.3K ﹤0.01%
1,236
+418
+51% +$5.96K
EEMV icon
3744
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.61B
$17.3K ﹤0.01%
311
+261
+522% +$14K
INMB icon
3745
INmune Bio
INMB
$56.6M
$17.3K ﹤0.01%
1,534
-1,009
-40% -$8.46K
HBB icon
3746
Hamilton Beach Brands
HBB
$443M
$17.3K ﹤0.01%
987
+746
+310% +$10.5K
TNYA icon
3747
Tenaya Therapeutics
TNYA
$164M
$17.3K ﹤0.01%
5,324
-7,567
-59% -$16.3K
BTBD icon
3748
BT Brands
BTBD
$7.98M
$17.2K ﹤0.01%
6,895
-5,278
-43% -$10.5K
GYRE icon
3749
Gyre Therapeutics
GYRE
$706M
$17.1K ﹤0.01%
666
+398
+149% +$5.65K
ELTX icon
3750
Elicio Therapeutics
ELTX
$82.7M
$17.1K ﹤0.01%
2,045
+2,007
+5,282% +$13.1K
148 149
150
151 152

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2023 Portfolio in Review

As of Q4 2023, Tower Research Capital (TRC) held 6,444 positions worth $8.1B, up 153% from $3.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $4.22B of net new capital in Q4 2023, opening 505 new positions and adding to 3,426 existing holdings. Its largest new stake was Veralto: 28,523 shares worth $2.35M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $21.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2023 buy was Veralto: 28,523 shares worth $2.35M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $314M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $21.7M.
  • Tower Research Capital (TRC) fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2023, selling an estimated $6.02M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $8.1B portfolio in Q4 2023.
  • Tower Research Capital (TRC) opened 505 new positions and closed 524 in Q4 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 153% quarter-over-quarter to $8.1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.